Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Chemical Biology

• Publication date

  2018-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nchembio.2528PMID 29200206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular basis of USP7 inhibition by selective small-molecule inhibitors

  2017cited by this paper
• Modulation of the p53/MDM2 interplay by HAUSP inhibitors.

  2017cited by this paper
• USP7 small-molecule inhibitors interfere with ubiquitin binding

  2017cited by this paper
• Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.

  2017cited by this paper
• Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.

  2017cited by this paper
• Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.

  2017cited by this paper
• Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors

  2016cited by this paper
• MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes

  2016cited by this paper
• The increasing complexity of the ubiquitin code

  2016cited by this paper
• Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

  2016cited by this paper
• K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression

  2016cited by this paper
• Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.

  2016cited by this paper
• HAUSP deubiquitinated and stabilizes N-Myc in neuroblastoma

  2016cited by this paper
• Drugging the undruggables: exploring the ubiquitin system for drug development

  2016cited by this paper
• Inhibiting the deubiquitinating enzymes (DUBs).

  2015cited by this paper
• Drug makers target ubiquitin proteasome pathway anew

  2015cited by this paper
• Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling.

  2015cited by this paper
• Deubiquitinase inhibition as a cancer therapeutic strategy.

  2015cited by this paper
• DUBs, the regulation of cell identity and disease.

  2015cited by this paper
• SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression.

  2014cited by this paper
• Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

  2014cited by this paper
• Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218)

  2014cited by this paper
• Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.

  2014cited by this paper
• USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy.

  2014cited by this paper
• Screening of DUB activity and specificity by MALDI-TOF mass spectrometry

  2014cited by this paper
• Development of inhibitors in the ubiquitination cascade

  2013cited by this paper
• MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.

  2013cited by this paper
• Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity.

  2013cited by this paper
• Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells

  2013cited by this paper
• Deubiquitylases from genes to organism.

  2013cited by this paper
• Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences

  2013cited by this paper
• Biophysical and computational fragment-based approaches to targeting protein–protein interactions: applications in structure-guided drug discovery

  2012cited by this paper
• Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.

  2012cited by this paper
• Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.

  2012cited by this paper
• The Ubiquitin-Specific Protease USP7 Modulates the Replication of Kaposi's Sarcoma-Associated Herpesvirus Latent Episomal DNA

  2012cited by this paper
• Characterization of Selective Ubiquitin and Ubiquitin-Like Protease Inhibitors Using a Fluorescence-Based Multiplex Assay Format

  2011cited by this paper
• Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

  2011cited by this paper
• Enzymatic Characterisation of USP7 Deubiquitinating activity and Inhibition

  2011cited by this paper
• The Multifaceted Roles of USP7: New Therapeutic Opportunities

  2011cited by this paper
• Features and development of Coot

  2010cited by this paper
• Inactivation of HAUSP in vivo modulates p53 function

  2010cited by this paper
• Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells

  2009cited by this paper
• Dissection of USP catalytic domains reveals five common insertion points.

  2009cited by this paper
• The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network

  2008cited by this paper
• A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

  2008cited by this paper
• A Simple Assay for Detection of Small-Molecule Redox Activity

  2007cited by this paper
• FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP

  2006cited by this paper
• Tumour suppression: Disruption of HAUSP gene stabilizes p53

  2004cited by this paper
• HAUSP is Required for p53 Destabilization

  2004cited by this paper
• research papers Acta Crystallographica Section D Biological

  2003cited by this paper
• Protein Profiling with Epstein-Barr Nuclear Antigen-1 Reveals an Interaction with the Herpesvirus-associated Ubiquitin-specific Protease HAUSP/USP7*

  2003cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein.

  1994cited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowncited by this paper

• Computational modeling of ubiquitin specific protease 7 (USP7) complexes with N-benzylpiperidinol derivatives incorporating binding site flexibility.

  2026cites this paper
• Design, Synthesis, and Molecular Evaluation of SNAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode

  2025cites this paper
• Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

  2025cites this paper
• Structures of USP7 in active and inactive states bound to DNMT1 revealed by cryo-EM.

  2025cites this paper
• AKT and DUBs: a bidirectional relationship

  2025cites this paper
• Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation

  2025cites this paper
• Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.

  2025cites this paper
• Discovery of indane and naphthalene derivatives as USP7 inhibitors.

  2025cites this paper
• Mechanistic Insights into the Mechanism of Allosteric Inhibition of Ubiquitin-Specific Protease 7 (USP7)

  2025cites this paper
• Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30

  2025cites this paper
• Structure-based discovery of novel non-covalent small molecule inhibitors of USP30

  2025cites this paper
• Rational Computational Workflow for Structure-Guided Discovery of a Novel USP7 Inhibitor

  2025cites this paper
• EDA photochemistry using continuous flow

  2025cites this paper
• Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies.

  2025cites this paper
• Targeting Ubiquitin-Specific Protease 7 (USP7): A Pharmacophore-Guided Drug Repurposing and Physics-Based Molecular Simulation Study

  2025cites this paper
• Therapeutic potential of targeting ubiquitin-specific proteases in colorectal cancer.

  2025cites this paper
• Computational analysis of energetic features and intermolecular interactions in protein-inhibitor USP7 complexes.

  2025cites this paper
• Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP

  2025cites this paper
• Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach.

  2025cites this paper
• Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)

  2025cites this paper
• USP7 V517F mutation as a mechanism of inhibitor resistance

  2025cites this paper
• Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7.

  2025cites this paper
• Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects

  2025cites this paper
• Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors.

  2025cites this paper
• USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis

  2025cites this paper
• Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7).

  2025cites this paper
• Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer.

  2025cites this paper
• E. coli-mediated expedient biosynthesis of biotin-labeled ubiquitin probe enables activity-based profiling of deubiquitinases in cytoplasmic and nuclear compartments

  2025cites this paper
• Enantioselective OTUD7B fragment discovery through chemoproteomics screening and high-throughput optimisation

  2025cites this paper
• The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer.

  2025cites this paper
• The role of ubiquitination in health and disease

  2024cites this paper
• Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo Activity.

  2024cites this paper
• PROTAC as a novel anti-cancer strategy by targeting aging-related signaling.

  2024cites this paper
• Stereo-selectivity of enantiomeric inhibitors to ubiquitin-specific protease 7 (USP7) dissected by molecular docking, molecular dynamics simulations, and binding free energy calculations

  2024influential citation
• USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53

  2024cites this paper
• Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy.

  2024cites this paper
• Ubiquitin-specific proteases (USPs) in leukemia: a systematic review

  2024cites this paper
• Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia.

  2024cites this paper
• Structural basis for the bi-specificity of USP25 and USP28 inhibitors

  2024cites this paper
• Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity.

  2024cites this paper
• USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF

  2024cites this paper
• USP7-Based Deubiquitinase-Targeting Chimeras Stabilize AMPK.

  2024cites this paper
• Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway

  2024cites this paper
• Rolapitant treats lung cancer by targeting deubiquitinase OTUD3

  2024cites this paper
• Backbone 1H, 13C and 15N resonance assignment of the ubiquitin specific protease 7 catalytic domain (residues 208–554) in complex with a small molecule ligand

  2024cites this paper
• Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents.

  2024cites this paper
• Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy.

  2024cites this paper
• A comprehensive review: Protein homeostasis and an emerging therapeutic target.

  2024cites this paper
• Virtual screening of natural products targeting ubiquitin-specific protease 7

  2024cites this paper
• Recent advances in the development of deubiquitinases inhibitors as antitumor agents.

  2024cites this paper
• Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1

  2024cites this paper
• miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia

  2023cites this paper
• Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer

  2023cites this paper
• Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative

  2023cites this paper
• USP7 - a crucial regulator of cancer hallmarks.

  2023cites this paper
• Preparation of UFM1-Derived Probes through Highly Optimized Total Chemical Synthesis.

  2023cites this paper
• Recent Progress of Ubiquitin-Specific-Processing Protease 7 Inhibitors

  2023cites this paper
• Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21

  2023cites this paper
• Development of a robust HTRF assay with USP7 full length protein expressed in E. coli prokaryotic system for the identification of USP7 inhibitors.

  2023cites this paper
• The Emerging Role of Deubiquitinases in Radiosensitivity.

  2023cites this paper
• Deubiquitylating Enzymes in Cancer and Immunity

  2023cites this paper
• Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment

  2023cites this paper
• USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation

  2023cites this paper
• ISGylation-independent protection of cell growth by USP18 following interferon stimulation

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy

  2022cites this paper
• Targeting the deubiquitinase USP7 for degradation with PROTACs.

  2022cites this paper
• On the Study of Deubiquitinases: Using the Right Tools for the Job

  2022influential citation
• Backbone and ILV side-chain NMR resonance assignments of the catalytic domain of human deubiquitinating enzyme USP7

  2022cites this paper
• A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present)

  2022cites this paper
• Recent advances in the pharmacological targeting of ubiquitin-regulating enzymes in cancer.

  2022cites this paper
• Hydrogen bonding penalty used for virtual screening to discover potent inhibitors for Papain‐Like cysteine proteases of SARS‐CoV‐2

  2022cites this paper
• Virtual Screening Inhibitors of Ubiquitin‐specific Protease 7 Combining Pharmacophore Modeling and Molecular Docking

  2022cites this paper
• Research Progress for Targeting Deubiquitinases in Gastric Cancers

  2022cites this paper
• Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer.

  2022cites this paper
• Discovery of a Potent and Selective Degrader for USP7.

  2022cites this paper
• Targeting PTEN Regulation by Post Translational Modifications

  2022cites this paper
• The equilibrium of tumor suppression: DUBs as active regulators of PTEN

  2022cites this paper
• USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective

  2022cites this paper
• Structural basis for specific inhibition of the deubiquitinase UCHL1

  2022cites this paper
• The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review

  2022cites this paper
• Targeting the ubiquitin system by fragment-based drug discovery

  2022influential citation
• Design, synthesis and biological evaluation of 2-aminopyridine derivatives as USP7 inhibitors.

  2022cites this paper
• Highlights in USP7 inhibitors for cancer treatment

  2022cites this paper
• The deubiquitylase USP31 controls the Chromosomal Passenger Complex and spindle dynamics

  2022cites this paper
• Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint

  2022cites this paper
• Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors

  2021cites this paper
• The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery

  2021cites this paper
• Enhanced Live‐Cell Delivery of Synthetic Proteins Assisted by Cell‐Penetrating Peptides Fused to DABCYL

  2021cites this paper
• Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors.

  2021cites this paper
• USP15: a review of its implication in immune and inflammatory processes and tumor progression

  2021cites this paper
• Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance

  2021cites this paper
• Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors

  2021cites this paper
• Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2

  2021cites this paper
• Structure Activity Relationship of USP5 Allosteric Inhibitors

  2021cites this paper
• The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia

  2021cites this paper
• Protein Function | Allostery in Proteins: Canonical Models and New Insights

  2021cites this paper
• Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.

  2021cites this paper
• Small molecules as tools for functional assessment of deubiquitinating enzyme function.

  2021cites this paper
• Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential

  2021cites this paper